LIAISON® SARS-CoV-2 Ag assay is a unique quantitative solution to detect suspected COVID-19 individuals, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2. LIAISON® SARS-CoV-2 Ag assay could help to keep the COVID-19 pandemic at bay, because specimens can be tested out rapidly in a great numbers.
- Long TAT of molecular testing can preclude clinical utility of the test
- To offer a cost-effective solution alternative to RT-PCR
- Allow to process a high volume of samples and to improve traceability at time to result during outbreak
- To screen asymptomatic people and to identify the hidden sources of COVID-19 transmission
Liaison SARS-CoV-2 AG is manufactured in the United States by Diasorin Inc. and was approved by Health Canada on November 2, 2021.
Buy Liaison SARS-CoV-2 AG for Your WorkPlace
If your company or organization is interested in rapid testing solutions, contact us today for help procuring Liaison SARS-CoV-2 AG or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
